RSPI fundamentals
An in-depth look to RespireRx Pharmaceuticals Inc. operating, investing, and financing activities
RSPI free cash flow for Q3 23 is -100.96 k USD. For 2022, RSPI free cash flow was -143.9 k USD and operating cash flow was -143.91 k USD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM